S.H.Kelkar &Co. Ltd. Buy. Proxy FMCG Play. Outlook & Valuation. November 16, 2015



Similar documents
Strong operational performance

Outlook and valuation

Share gains with healthy margin uptick; Retain Buy

Results impacted by subdued demand

Tata Motors Ltd. Buy. New launches at domestic business as well as JLR to drive growth. February 12, 2016

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Company Overview. Financial Performance

Flexituff International Ltd. (FIL)

Maruti Suzuki. Source: Company Data; PL Research

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

Margins to remain in mid 15% range for FY 16E, increase in FY 17E on operating leverage

Higher other income drive the quarter

Gujarat State Petronet Ltd. INR 135

India Equity Research Telecommunications September 2, 2015 Management Meet Update

Britannia Industries

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

Simplex Infrastructures

How To Value Hpl In India

The Ramco Cements. Source: Company Data; PL Research

Jubilant Life Sciences

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP Target Price JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

Mangalam Cement Weak volumes marred performance

Kotak Mahindra Bank Rs 685

Minda Industries Ltd. INR 886

GAIL (India) Ltd. INR 346

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

RamKrishna Forgings Ltd.

HCC BUY. Infrastructure January 29, 2016

GlaxoSmithKline Consumer Healthcare

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Tree House Education & Accessories

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Techno Electric & Engineering Limited

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

Navin Fluorine International

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

CMP: JUNE 2016 SWARAJ ENGINES LTD

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Aurobindo Pharma. Source: Company Data; PL Research

Va Tech Wabag. Source: Company Data; PL Research

Sphere Global Services Limited

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP Target Price SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

Khambatta Securities Ltd.

Just Dial Ltd Bloomberg Code: JUST IN

Company Profile. VIP Industries

Quant Picks United Breweries

BUY. Key Risks. Technology - Technology Services - Information Services. Nov 19, CRISIL Ltd. Recommendation (Rs.)

Larsen & Toubro. Source: Company Data; PL Research

BUY RSWM LTD SYNOPSIS. CMP Target Price SEPTEMBER 1 st Result Update(PARENT BASIS): Q1 FY16

BUY. JYOTHY LABORATORIES LTD Result Update (CONSOLIDATED BASIS): Q2 FY16. CMP Target Price DECEMBER 29 th 2015.

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

Pidilite Industries. Source: Company Data; PL Research

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

Smruthi Organics Limited BSE Scrip Code:

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

Granules India Ltd. INR 113

infotech.com SECTOR: IT SOFTWARE REPORTING DATE: 31 ST MAY, i Infotech Ltd.

East India Hotels (EIH) Ltd Growing Strategically

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

Sadbhav Engineering. Weak execution, but strong order outlook. Source: Company Data; PL Research

UltraTech Cement Ltd.

SECTOR: REALTY REPORTING DATE: 31 ST MAY, 2016 PVP Ventures Ltd

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Investment Rationale

Black Rose Industries Ltd Sector Industry

Credit Analysis and Research Ltd. CARE : SUBSC RIBE 4th December, Financial summary (Consolidated) - Rs. mn

Increasing estimates and PT on expectation of solid earnings momentum. Growth momentum and turnaround of insurance business

Private drilling fluid technology service leader

Bright Smart (1428 HK)

Dr. Reddy's Laboratories

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

Butterfly Gandhimathi (GANAP) 188

MATELAN Research. Intelligent Transportation Systems MEGATRENDS DRIVE MARKET GROWTH FINANCIALS ACCELERATING IVU AND INIT SHOW HIGHEST UPSIDES

Bharat Earth Movers (BEML)

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

MAITHAN ALLOYS LTD Result Update (PARENT BASIS): Q4 FY16

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

IFGL REFRACTORIES LTD. RESULT UPDATE PRESENTATION, February 2016

JLR Nov-15 wholesale up 24% YoY to 51,021 units

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

Bata India Ltd. (BIL)

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, Target Price Rs220. IT India.

SJVN BUY. Robust performance continues, reiterate BUY. Results Review INDIA TP: INR % SJVN IN

Year-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14

MOSt Market Outlook 1st, July 2016

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

BDI BioEnergy Internat Buy

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

ZetaDisplay. Europe leads the way. EPaccess

Focus on fleet customers SAF-HOLLAND Annual Financial Statements 2013

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

Zee Entertainment BUY. Outlook steady; expect another strong quarter. Company Update INDIA TP: INR % Z IN

Transcription:

November 16, 2015 Buy S.H.Kelkar &Co. Ltd Industry: Fragrance and Flavor Industry View: Overweight Initiating Coverage Proxy FMCG Play SHK is the largest domestic fragrance manufacturer with ~ 20.5% market share in the Indian fragrance industry and exports to over 52 countries. It is also an emerging flavor producer in India with ~ 2% market share and exports reaching 15 countries. SHK has over 4,100 customers which include leading national and MNC FMCG companies, blenders and producers of fragrances and flavors. Total manufacturing capacity is ~ 19,819 tons p.a. with 3 plants in India and 1 in The Netherlands. It has a research team of 18 scientists based in Mumbai and Barneveld. It also has 12 perfumers, 2 flavorists, evaluators and application executives at their 5 creation and development centers in India, The Netherlands and Indonesia. Its SHK, Cobra and Keva brands enjoy substantial brand equity. Strong reputation built on quality and continual R & D to help sustain market share. SHK is the 3 rd largest fragrance player in India with a strong reputation built over 90 years of its existence. With a solid business model, an 8,000 wide product range and effective sales & marketing capabilities as demonstrated by its 95 member robust sales team, we believe that SHK would be able to sustain its market share in the ~ 20 bn Indian fragrance industry which in itself has witnessed a CAGR of 10.1% over the last 4 years. Low financial risk on account of reduced leverage and no significant capex plans. SHK plans to use ~ 2 bn raised in its IPO to pay off its working capital loans and other long term debt. Also, SHK has already completed its capex cycle for the next 3-5 years with its Indian plants working at 35% - 45% capacity. Thus we expect that the repayment of significant debt post issue combined with an absence of material capex plans would ensure that financial risk is contained over the medium term. Favorable demand side dynamics continue to support the top-line. With a growing FMCG sector in Asia, North Africa and Middle East which constitutes ~ 83.7% of SHKs revenues, favorable demographics in place & customer diversity both in terms of low client concentration and ~ 43.5% of revenues coming from exports, we expect SHK to be an effective FMCG proxy. Potential upside offered by branded small packs and flavor businesses. SHK plans to deepen its distribution network, introduce new products and new application methods for its fragrance small packs business. With capacity available in its flavor manufacturing facility, established brand equity and a growing clientele currently over 400, we expect SHK to increase its market share in the flavor industry which has grown at a CAGR of 10.4% over the last 4 years. Outlook & Valuation We believe SHK to be a proxy FMCG play and should trade at premium valuations akin to FMCG companies. We initiate coverage on SHK with a BUY rating and a 15 month price objective of 280 (40% upside) Stock Data Current Market Price ( ) 201 Target Price ( ) 280 Potential upside (%) 40 Market Cap ( bn) 29.4 Bloomberg Reuters Share Holding (Post-Issue) Fiscal YE YE Mar SHKL IN NA FY14 FY15 FY16E FY17E FY18E Revenues 7,614 8,370 9,375 10,640 12,236 Material Cost 3,991 4,656 5,109 5,852 6,840 Others 2,252 2,521 2,834 3,181 3,579 EBITDA 1,370 1,193 1,431 1,607 1,817 Depreciation 188 293 228 204 187 Other Income 78 233 80 96 109 EBIT 1,261 1,133 1,283 1,499 1,739 Finance Cost 175 186 146 6 5 Tax 294 304 341 448 520 PAT 791 644 796 1,045 1,214 Key Ratios YE Mar Noninstitutional 43.3% Promoter & promoter group 56.7% FY14 FY15 FY16E FY17E FY18E EPS 5.5 4.5 5.5 7.2 8.4 EBITDA Margin 18.0% 14.3% 15.3% 15.1% 15.0% PAT Margin 10.3% 7.5% 8.4% 9.7% 9.8% P/E 36.7 45.2 36.5 27.8 23.9 P/B 6.0 5.7 3.7 3.4 3.1 EV/Sales 4.0 3.6 3.0 2.7 2.3 EV/EBITDA 22.3 25.5 19.9 17.6 15.5 ROCE 22.9% 20.6% 16.3% 17.4% 18.5% ROE 16.4% 12.6% 10.1% 12.2% 13.0% Yashas Bhat yashas_bhat@lkpsec.com +91 22 6635 1220

Company Profile S.H.Kelkar &Co. Ltd. SHK is the largest domestic fragrance producer commanding ~ 20.5% market share in the Indian fragrance industry with over 9,700 fragrances, fragrance ingredients and flavors created, manufactured and supplied as on FY15. It has a long standing reputation developed over its 90 year history as a supplier of quality fragrances for use by FMCG companies in personal and home care products, food and beverage industries with exports to over 52 countries. It is also an emerging flavor producer in India with exports of its flavor products reaching 15 countries. SHK has a large and diverse mix of over 4,100 customers which include leading national and MNC FMCG companies, blenders as well as producers of fragrances and flavors. It has 4 manufacturing facilities, 3 of which are located in India and 1 in The Netherlands, the total annual installed manufacturing capacity being ~ 19,819 tons. It has a dedicated research team of 18 scientists operating out of their facilities located in Mumbai and Barneveld. It also has a team of 12 perfumers, 2 flavorists, evaluators and application executives at their 5 creation and development centers in Mumbai, Bengaluru, The Netherlands and Indonesia. The SHK, Keva and Cobra brands through which it sells its products enjoy substantial brand equity in India. Brands of SHK LKP Research 2

S.H.Kelkar &Co. Ltd Investment Argument Proven track record, continual introduction of new fragrances, high product quality standards to help SHK sustain its market share Strong reputation built on high quality standards and continual R & D to help sustain market share. SHK is the 3 rd largest fragrance company in India by revenue, with a market share of ~ 20.5%. Its competitors are mainly MNCs such as Givaudan SA, Firmenich, International Flavors and Fragrances Inc. and Symrise SA which collectively hold a 57.0% market share of the global fragrance and flavor industry. Market Share of fragrance industry players in India. Others 15% Givaudan 26% IFF 7% Symrise 10% SHK 21% Firmenich 21% Source:Company, LKP Research SHK has always pushed its boundaries with new unique offerings to help enhance user experience of FMCG products containing these fragrances. In FY15 itself, SHK developed over 502 new fragrance and flavor compounds which have been sold commercially. Its research team developed 12 molecules over the last 3 years, out of which it has filed patent applications for 3. It combines its innovation efforts with a strong quality control system which enables traceability and repeatability for each batch of its products. This has led to a contribution of ~ 14.3% of revenues in FY15 from product launches of the last 3 financial years. We believe that SHK has built a very strong reputation through delivery of quality products and customer satisfaction in the 90 years of its existence. With a solid business model, an 8,000 wide fragrance product range and strong sales & marketing capabilities as demonstrated by its robust sales team of 95 people from 9 centers in India and overseas, we believe that SHK would be able to sustain its market share in the ~ 20 bn Indian fragrance industry which in itself has witnessed a CAGR of 10.1% over the last 4 years. Inelastic demand, high switching costs and a diversified customer base to support top-line Favorable demand side dynamics continue to support the top-line. The fragrance industry is primarily a niche market. Customers majorly include FMCG players who mainly use these fragrances in the manufacture of demand inelastic daily utilities like home and personal care products. This $ 47.3 bn Indian FMCG industry which has witnessed a CAGR of ~ 13.0% from FY07 to FY15 is expected to continue its stable growth phase on account of a large consumer base, shift of households to a more aspirational lifestyle and a clear uptrend in the share of non-food expenditure in India because of rising income levels. This coupled with demand inelasticity is expected to drive demand in the Indian fragrance industry. LKP Research 3

S.H.Kelkar &Co. Ltd Demand Drivers in Indian fragrance industry. Others 31% Home Care 21% Personal Wash 15% Hair Care 11% Source:Company, LKP Research Beauty Care 11% Fragrance manufacturers are involved from an early stage of product development and there is a requirement for consistency in its smell and quality. Most FMCG companies depend on the reliability & quality of service of fragrance producers and their knowledge & understanding of their products and needs. In addition to this, fragrance procurement has a relatively small share in overall production costs for FMCG goods. Thus, there is an element of customer stickiness on account of these factors which helps fragrance producers in long term client retention. Notable Clients of SHK for fragrance offerings Fabric Care 11% SHKs fragrance business has a diversified customer base of over 3,700 customers consisting of leading national and MNC FMCG companies, blenders as well as producers of fragrances. A distinct advantage it enjoys is low customer concentration. Out of the net revenue from operations of ~ 8.4 bn and ~ 2.2 bn in FY15 and Q1FY16E, revenue from SHKs largest customer was ~ 240 Mn and ~ 88 Mn respectively. This amounts to only ~ 2.9% and ~ 3.9% of revenues from SHKs biggest customer in FY15 and Q1FY16E. Thus, with a low concentration risk, SHK has managed to effectively mitigate the adverse effect of client loss on its topline and bottom-line. Revenues from exports form a significant part of SHKs top-line. Its revenues are majorly driven by FMCG and fragrance consumption in emerging markets comprising of Asia, Middle East and North Africa (A & MENA). LKP Research 4

S.H.Kelkar &Co. Ltd. FY15 - Domestic and Exports Revenues FY15 - Share of A & MENA in Revenues Domestic ( 4.7 Bn ) 56.5% Overseas ( 3.7 Bn) 43.5% A & MENA ( 7.0 Bn) 83.7% Others ( 1.4 Bn) 16.3% Source: Company, LKP Research Q1FY16E -Domestic and Exports Revenues Q1FY16E- Share of A & MENA in Revenues Domestic ( 1.4 Bn ) 64.1% Overseas ( 0.8 Bn ) 35.9% A & MENA ( 1.9 Bn) 85.9% Others ( 0.3 Bn) 14.1% Source: Company, LKP Research Low financial leverage and sufficient capacity for the medium term to keep financial risks subdued Thus, with a growing FMCG sector in India and other emerging markets, favorable demographics in place as well as customer diversity both in terms of low client concentration and significant exports, we expect SHK to be an effective FMCG proxy. We believe that the top-line of SHK will continue expanding at a considerable pace which in turn may augment profitability. Low financial risk on account of reduced leverage and no significant medium term capex plans. Out of the ~ 5 bn IPO issue in Oct 15, ~ 3 bn was towards a partial exit by Blackstone Capital and the remaining ~ 2 bn is to be used to retire working capital loan and other debt of SHK and its subsidiary KV Arochem. With negligible debt and consequent low interest burden, SHK would enjoy the benefits of reduced financial risks and low leverage. This would help the company sustain its high growth phase where its bottom-line has grown at a CAGR of 15.4% from FY11 to FY15. Details of manufacturing plants of SHK Location Annual Capacity (tons) Utilisation (%) Raigad, Maharashtra 10,342 44.2% Mumbai, Maharashtra 4,599 40.5% Vapi, Gujarat 2,064 35.8% Barnveld, The Netherlands 1,650 (metric) 77.2% LKP Research 5

S.H.Kelkar &Co. Ltd The company has 4 fragrance manufacturing facilities, 3 in India and 1 in The Netherlands. The manufacturing facilities in India are working at a 35-45% capacity as SHK has already completed its capex cycle for the next 3-5 years and is looking to achieve economies of scale with increased demand and production. Thus the repayment of significant long term debt post issue combined with an absence of material capex plans would ensure that financial risk is contained over the medium term, further cementing the case of SHK as an effective FMCG proxy. Branded small packs provides a steady stream of cash flows independent from FMCG industry, flavor business is largely untapped Potential upside offered by branded small packs and flavor businesses. SHK also has a small pack fragrance business which it operates through its Cobra brand. This business includes sales of its fragrance products in package sizes ranging from 25 gm to 25 kg to several hundred traders and resellers spread country-wide. The contribution of this business to the top-line is given below. Pack Size FY15 Q1FY16E mn % of Revenues mn % of Revenues 25 gm - 500 gm 512 6.1 183 8.3 500 gm- 25 kg 630 7.5 150 6.8 Total 1,142 13.6 333 15.1 Snapshot of Indian Flavor Industry. Recognizing the potential of this revenue stream, SHK aims to deepen its distribution network and introduce a new sales strategy which would include a dedicated small pack sales team. With plans to introduce new products and new application methods for its fragrance products in the small packs business, we expect the Cobra brand to grow and support its top-line growth. Demand Drivers in Indian flavor industry Share of market players in Indian flavor industry. Oral Hygiene 12% Others 24% Beverages 41% SHK 2% Firmenich 6% Symrise 10% Others 42% Bakery 23% Givaudan 19% IFF 21% Source:Company, LKP Research SHK is also an emerging player in the flavor industry with exports of this business reaching over 15 countries. With a diverse portfolio of 1,100 flavor products, this business has over 400 customers including manufacturers of beverages, confectionary, dairy products, bakery products, pharmaceuticals, oral hygiene, etc. It manufactures these products in its Raigad facility, details of which are stated below. Facility Installed Capacity Capacity Utilisation FY15 Q1FY16E Raigad, Maharashtra 1,164 34% 31% LKP Research 6

S.H.Kelkar &Co. Ltd Notable Clients of SHK for flavor offerings SHK has a small 2% share in the Indian flavor industry which is dominated by global leaders. With capacity available with SHK to take advantage of an industry growing at a stable CAGR of 10.4% over the last 4 years, established brand equity with its fragrance and flavor products and a growing clientele of its flavor products currently over 400, we expect SHK to increase its market share in an expanding industry thereby further augmenting its growth. LKP Research 7

S.H.Kelkar &Co. Ltd. Financial Performance FMCG growth, continual R & D, increased focus in flavor and small pack businesses to drive revenues. Revenues ( mn). Revenues Revenues of SHK have grown at a healthy CAGR of ~ 13.0% from ~ 4.7 bn in FY11 to ~ 8.6 bn in FY15 driven by consistent demand for its fragrances from FMCG companies in India and overseas where it has a significant exposure in A & MENA. 14,000 12,000 10,000 8,000 6,000 4,670 5,740 6,677 7,692 8,603 9,455 10,736 12,345 4,000 2,000 - FY11 FY12 FY13 FY14 FY15 FY16E FY17E FY18E Source:Company, LKP Research Efficient raw material sourcing essential to maintain and improve EBITDA margins The fortunes of SHK depend of the level of FMCG consumption in India and overseas. With average household incomes of SHKs target market expected to significantly expand with an increasing share of disposable income, a favorable population composition and expansion of modern retail formats, consumption of FMCG products is all set to follow a healthy growth trajectory. Also, in order to keep up with changing preferences of the ultimate consumer, SHK consistently invests in research and development. It spent ~ 264 mn and ~ 62mn in FY15 and Q1FY16E which comes to ~ 3.1% and ~ 2.8% of revenues respectively. We believe that a scenario of a thriving FMCG industry, continual innovation, introduction of new products, increased focus on developing its flavor and small pack fragrance businesses would benefit SHK and help its revenues grow at ~ 13.5% to ~ 10.7 bn in FY17E and ~ 15.0% to ~ 12.3 bn in FY18E respectively. EBITDA and EBITDA Margins SHK has been delivering decent EBITDA margins consistently from FY11 to FY15. It witnessed a fall in margins from ~ 18.0% in FY14 to ~ 14.3% in FY15 primarily because of increased material cost which went up from ~ 52.4% of operational revenues in FY14 to ~ 55.6% in FY15. It sources ~ 40%-45% of raw materials from countries like Indonesia, Germany, Brazil and US. EBITDA ( mn).and EBITDA Margins (%) 2,000 1,800 1,600 1,400 1,200 1,000 800 600 400 200 0 18.2% 18.3% 17.7% 18.0% 14.3% 15.3% 15.1% 15.0% 838 1,044 1,180 1,370 1,193 1,431 1,607 1,817 FY11 FY12 FY13 FY14 FY15 FY16E FY17E FY18E 20% 18% 16% 14% 12% 10% 8% 6% 4% 2% 0% Source:Company, LKP Research LKP Research 8

S.H.Kelkar &Co. Ltd Given the nature of fragrance and flavor industry, quality and specifications of raw materials used in its products is of high importance. With long standing relationships with its suppliers, we believe that SHK can economically source its raw materials. Efficient material costs coupled with effective control of employee benefits and other expenses are essential for SHKs sustainability in its margins. We expect that SHK would earn absolute EBITDA and margins of ~ 1.6 bn and ~ 15.1% in FY16E and ~ 1.8 bn and ~ 15.0% in FY17E respectively. Lower depreciation and negligible interest burden FY17E onwards to bolster PAT and PAT margins PAT and PAT Margins PAT and PAT margins for SHK stood at ~ 791 mn & ~ 10.3% in FY14 and ~ 644 mn & ~ 7.5% in FY15 respectively. This is the direct effect of an increased burden of higher material costs and depreciation post significant investments in fixed assets up to FY14. With SHKs capex cycle completed for the medium term and negligible interest burden after repayment of debt post issue, we expect PAT and PAT margins to steadily improve to ~ 1.0 bn & ~ 9.7% in FY17E and ~ 1.2 bn & ~ 9.8% in FY18E respectively. PAT ( mn).and PAT Margins (%) 1,400 1,200 1,000 800 600 400 200 0 10.3% 9.2% 9.7% 9.8% 8.4% 7.2% 7.5% 6.7% 315 412 616 791 644 796 1,045 1,214 FY11 FY12 FY13 FY14 FY15 FY16E FY17E FY18E 12% 10% 8% 6% 4% 2% 0% Source:Company, LKP Research Peer Group Analysis SHK has no real domestic peer as the Indian fragrance and flavor industry is dominated by a few global players like Givaudan SA, Firmenich, Symrise SA, IFF etc. Comparative price ratios of SHK with its global peers are given below. Particulars SHK Givaudan Symrise Country India Switzerland Germany Bloomberg SHKL IN GIVN:VX SY1:GR P/E 36.1 31.6 35.7 P/S 3.4 3.8 3.1 P/B 3.7 4.9 5.2 LKP Research 9

S.H.Kelkar &Co. Ltd. Risks & Concerns Most fragrance and flavor companies are now placing greater focus on emerging markets of Asia- Pacific, South America, Middle East and Africa due to growing urbanization and changing lifestyles which is expected to directly benefit FMCG companies and their fragrance & flavor suppliers. A trend of increasing consolidation is also being witnessed in these emerging economies with local established players being viewed as attractive acquisition targets. This is leading to intense competition in these markets which can adversely affect companies like SHK, with global players equipped with financial strength and international expertise. This can be witnessed by the fact that Givaudan SA has planned to invest FF 55 mn ( 3.7 bn) in a new manufacturing facility in Pune, Maharashtra which is expected to be operational by FY18E. SHK earns its revenues primarily from the FMCG sector. Thus, the fortunes of SHK are tied to the prospects of this industry inspite of SHK enjoying a low customer concentration. With events like the Nestle Maggi controversy having the potential to shake up entire product categories across the FMCG industry, this dependency may play out against SHK, especially where it is looking at its flavor industry to give impetus to its growth prospects. SHK has 12 perfumers, 2 flavorists and 17 skilled equipment operators. The company depends on a few specialized employees, which may be poached by its global counterparts, with better remuneration and the MNC appeal. SHKs failure to acquire and retain right talent may adversely affect product consistency, quality and its ability to introduce new fragrances and flavors. ~ 43.5% of its revenues come from exports, and ~ 40.0%-45.0% of raw materials have been from suppliers outside India, exposing the company to significant forex risks. Outlook & Valuation We believe SHK to be a proxy FMCG play and should trade at premium valuations akin to FMCG companies. We initiate coverage on SHK with a BUY rating and a 15 month price objective of 280 (40% upside) LKP Research 10

Financials (consolidated) Income statement YE Mar ( Mn) FY14 FY15 FY16E FY17E FY18E Net Revenues 7,614 8,370 9,375 10,640 12,236 Total Materials Cost 3,991 4,656 5,109 5,852 6,840 Employee Benefits 1,029 1,150 1,288 1,436 1,597 Others 1,222 1,371 1,547 1,745 1,982 EBITDA 1,370 1,193 1,431 1,607 1,817 EBITDA Margin (%) 18.0% 14.3% 15.3% 15.1% 14.9% Depreciation 188 293 228 204 187 Other Income 78 233 80 96 109 EBIT 1,261 1,133 1,283 1,499 1,739 EBIT Margin (%) 16.4% 13.2% 13.6% 14.0% 14.1% Finance Cost 175 186 146 6 5 PBT 1,085 947 1,138 1,493 1,735 PBT Margin (%) 14.1% 11.0% 12.0% 13.9% 14.1% Tax 294 304 341 448 520 PAT 791 644 796 1,045 1,214 PAT Margin (%) 10.3% 7.5% 8.4% 9.7% 9.8% Diluted EPS 5.5 4.5 5.5 7.2 8.4 Cash Flow YE Mar ( Mn) FY14 FY15 FY16E FY17E FY18E PBT 1,085 947 1,138 1,493 1,735 Depreciation 188 293 228 204 187 Finance Cost 175 186 146 6 5 Other income (78) (233) (80) (96) (109) Change in Working Capital 105 6 (2,438) (671) (700) Less: Tax (294) (304) (341) (448) (520) CF from Operations (a) 1,181 896 (1,348) 488 597 Capital Expenditure (548) (169) (107) (125) (125) Goodwill on Consolidation (121) 48 - - - Change in /Investments 412 2 (25) (25) - Other income 78 233 80 96 109 CF from Investing (b) (179) 114 (52) (54) (17) Free Cash Flow (a+b) 1,002 1,009 (1,400) 434 580 Issue of Equity Shares - - 2,100 - - Long Term Debt 214 (298) (361) (6) (6) Interest paid (175) (186) (146) (6) (5) Amalgamation adjustment (782) - - - - Payment of Dividend (150) (149) (187) (260) (361) DDT (25) (31) (37) (52) (72) CF from Financing (c) (919) (664) 1,369 (324) (444) Net Change (a+b+c) 83 345 (31) 110 136 Closing Cash and CE 414 760 729 839 975 Source: Company, LKP Research S.H.Kelkar &Co. Ltd. Balance sheet YE Mar ( Mn) FY14 FY15 FY16E FY17E FY18E SOURCES OF FUNDS Equity Share Capital 132 1,323 1,446 1,446 1,446 Preference Share Capital 9 92 - - - Reserves and Surplus 4,669 3,688 6,402 7,135 7,917 Total Net Worth 4,810 5,103 7,848 8,582 9,363 Total Long Term Debt 689 391 29 23 17 Total Liabilities 5,499 5,493 7,877 8,605 9,380 APPLICATION OF FUNDS Fixed Asset 2,189 2,065 1,944 1,865 1,804 Goodwill on consolidation 828 780 780 780 780 Investments 2 0 25 50 50 Others 213 286 329 353 373 Current Assets Cash and Bank 414 760 729 839 975 Inventories 2,788 3,175 3,552 4,050 4,705 Sundry Debtors 1,794 1,947 2,183 2,478 2,850 Loans & Advances 283 233 322 376 425 Others 4 42 51 45 41 Current Liabilities and Provisions Trade Payables 879 1,016 1,127 1,277 1,518 Short Term Borrowings 1,149 1,745 61 13 - Other Current Liabilities 739 738 558 572 628 Provisions 249 296 292 370 476 Net Current Assets 2,267 2,362 4,799 5,556 6,373 Total Assets 5,499 5,493 7,877 8,605 9,380 Key Ratios YE Mar FY14 FY15 FY16E FY17E FY18E Per Share Data (Rs) EPS 5.5 4.5 5.5 7.2 8.4 CEPS 6.8 6.5 7.1 8.6 9.7 BVPS 33.3 35.3 54.3 59.3 64.7 DPS 1.0 1.0 1.3 1.8 2.5 Growth Ratios(%) Revenues from operations 14.3% 9.9% 12.0% 13.5% 15.0% EBITDA 16.1% -12.9% 19.9% 12.3% 13.1% PAT 28.5% -18.6% 23.7% 31.2% 16.2% Valuation Ratios (X) P/E 36.7 45.2 36.5 27.8 23.9 P/CEPS 29.7 31.0 28.4 23.3 20.8 P/B 6.0 5.7 3.7 3.4 3.1 EV/Sales 4.0 3.6 3.0 2.7 2.3 EV/EBITDA 22.3 25.5 19.9 17.6 15.5 FCF/EBITDA 0.7 0.8 (1.0) 0.3 0.3 Profitability Ratios (%) ROCE 22.9% 20.6% 16.3% 17.4% 18.5% ROE 16.4% 12.6% 10.1% 12.2% 13.0% Dividend payout 19.0% 23.2% 23.4% 24.8% 29.7% Dividend Yield 0.5% 0.5% 0.6% 0.9% 1.2% LKP Research 11

S.H.Kelkar &Co. Ltd. DISCLAIMERS AND DISCLOSURES LKP Sec. ltd. (CIN-U67120MH1994PLC080039, www. Lkpsec.com) and its affiliates are a full-fledged, brokerage and financing group. LKP was established in 1992 and is one of India's leading brokerage and distribution house. LKP is a corporate trading member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited(NSE), MCX Stock Exchange Limited (MCX-SX).LKP along with its subsidiaries offers the most comprehensive avenues for investments and is engaged in the businesses including stock broking (Institutional and retail), merchant banking, commodity broking, depository participant, insurance broking and services rendered in connection with distribution of primary market issues and financial products like mutual funds etc. LKP hereby declares that it has not defaulted with any stock exchange nor its activities were suspended by any stock exchange with whom it is registered in last five years. However, SEBI and Stock Exchanges have conducted the routine inspection and based on their observations have issued advice letters or levied minor penalty on LKP for certain operational deviations in ordinary/routine course of business. LKP has not been debarred from doing business by any Stock Exchange / SEBI or any other authorities; nor has its certificate of registration been cancelled by SEBI at any point of time. LKP offers research services to clients. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Other disclosures by LKP and its Research Analyst under SEBI (Research Analyst) Regulations, 2014 with reference to the subject company(s) covered in this report-: Research Analyst or his/her relative s financial interest in the subject company. (NO) LKP or its associates may have financial interest in the subject company. LKP or its associates and Research Analyst or his/her relative s does not have any material conflict of interest in the subject company. The research Analyst or research entity (LKP) has not been engaged in market making activity for the subject company. LKP or its associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report. Research Analyst or his/her relatives have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report: (NO) LKP or its associates may have received any compensation including for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. LKP or its associates may have received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. LKP or its associates may have received any compensation or other benefits from the Subject Company or third party in connection with the research report. Subject Company may have been client of LKP or its associates during twelve months preceding the date of distribution of the research report and LKP may have co-managed public offering of securities for the subject company in the past twelve months. Research Analyst has served as officer, director or employee of the subject company: (NO) LKP and/or its affiliates may seek investment banking or other business from the company or companies that are the subject of this material. Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that may be inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest including but not limited to those stated herein. Additionally, other important information regarding our relationships with the company or companies that are the subject of this material is provided herein. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject LKP or its group companies to any registration or licensing requirement within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any transaction to any U.S. person. Unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by private customers in United Kingdom. All trademarks, service marks and logos used in this report are trademarks or registered trademarks of LKP or its Group Companies. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Please ensure that you have read Risk Disclosure Document for Capital Market and Derivatives Segments as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. All material presented in this report, unless specifically indicated otherwise, is under copyright to LKP. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of LKP LKP Securites Ltd, 13th Floor, Raheja Center, Free Press Road, Nariman Point, Mumbai-400 021. Tel -91-22 - 66351234 Fax- 91-22-66351249. www.lkpsec.com